Factor XI
Factor XI (coagulation factor XI, FXI) is a secreted plasma serine protease of the blood coagulation cascade. Once activated, it triggers the middle phase of the intrinsic pathway of coagulation by activating factor IX. Browse Assay Genie's current range of Factor XI research reagents below, or read on for the biology behind the target.
Factor XI is a component of the blood coagulation cascade and circulates in plasma as a zymogen, an inactive precursor of a serine protease. It is an unusual plasma coagulation enzyme because it exists as a homodimer, made up of two identical polypeptide chains linked by disulfide bonds. During activation, factor XIIa (or factor XII) cleaves an internal peptide bond in each of the two chains. This produces activated factor XIa, a serine protease built from two heavy and two light chains held together by disulfide bonds.
Activated factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. The protein is secreted, and the F11 gene encodes it in humans, with a mouse ortholog also named F11. The HGNC places the gene in the groups of serine proteases and coagulation factors. In UniProt, factor XI belongs to the peptidase S1 family, plasma kallikrein subfamily, and its enzymatic activity is classified under EC 3.4.21.27.
Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality. For this reason, the Factor XI protein and the F11 gene are studied in work on the intrinsic pathway, zymogen activation and coagulation disorders. Researchers working with a Factor XI antibody or a Factor XI ELISA kit should check that the reagent suits the intended species and application.
Factor XI activates factor IX in the middle phase of the intrinsic pathway, making it a key enzyme for studying how coagulation proceeds.
Cleavage by factor XIIa converts the Factor XI zymogen into factor XIa, providing a model for protease activation in plasma.
Defects in Factor XI lead to Rosenthal syndrome, a blood coagulation abnormality, so the protein is relevant to bleeding disorder research.
Factor XI belongs to the peptidase S1 family, plasma kallikrein subfamily, and is useful for comparing structure and function among serine proteases.
Factor XI is a plasma zymogen that, once cleaved by factor XIIa, becomes the serine protease factor XIa. Activated factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX.
Factor XI is also called FXI, and its gene symbol is F11. The zymogen is a homodimer of two identical chains linked by disulfide bonds. Activated factor XIa has two heavy and two light chains, also held together by disulfide bonds.
Defects in Factor XI lead to Rosenthal syndrome, a blood coagulation abnormality. A mouse ortholog named F11 exists, so mouse models can be used in coagulation studies. Check the datasheet of any product for its validated reactivity.
Other coagulation factors, serine proteases and intrinsic pathway components that sit alongside Factor XI in research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P03951; product specifications from Assay Genie datasheets.